The CRYOFOCUS-B (06922) issued 5.595 million H shares under the general authorization.
Kangrun Biotech-B (06922) announced that, pursuant to the general authorization granted at the annual general meeting of shareholders held on June 20, 2025, it will issue 5,595,000 H shares through subscription.
CRYOFOCUS-B (06922) announced that, pursuant to the general authorization granted at the annual general meeting of shareholders held on June 20, 2025, 5,595,000 H shares will be issued by way of subscription.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
